AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Is IXICO Positioned to Transform Neurodegenerative Research on the FTSE AIM and fts100 Today?
May 20, 2025 10:31 PM AEST| By Team Kalkine MediaHighlights,IXICO reports increased revenue and gross profit amid continued contract growth,The company is rolling out advanced imaging tools for Parkinson's and related disorders,Cash reserves strengthened through fundraising, supporting product deve...
Can Poolbeg Pharma Overcome Biotech Hurdles with Breakthrough Therapies? | fts100 today
May 20, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Poolbeg Pharma PLC raises new funding to progress two biopharmaceutical assets addressing inflammation and obesity.,POLB 001 is being developed as an oral therapy to manage cytokine release syndrome linked with cancer treatments.,An oral G...
What Do Creo Medical's Results Indicate About Its Role in the FTSE Index Healthcare Segment?
May 20, 2025 09:30 PM AEST| By Team Kalkine MediaHighlights,Core technology revenue showed significant year-over-year growth driven by device adoption,Divestment in the consumables unit brought in strategic capital and strengthened partnerships,Expansion in customer base reflects rising interest in...
How Is This FTSE Healthcare Stock Strengthening Its AI Strategy in Neuroimaging?
May 20, 2025 05:31 PM AEST| By Team Kalkine MediaHighlights,IXICO PLC reported a rise in revenues and gross margin, reflecting gains from its “Innovate, Lead, Scale” strategy.,The company secured a key contract in Huntington’s disease trials and expanded operations in key therapeutic areas.,Artific...
What’s Driving Poolbeg Pharma’s Latest Fundraising Plan on the FTSE AIM Index?
May 20, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Poolbeg Pharma plans to raise funding through discounted share issuance and subscriptions to support clinical trials.,Proceeds will be used to advance programs in cancer immunotherapy and obesity treatment.,The company reported a strengthe...
What’s Driving Arecor’s Gains on the LSE as FTSE Prices Shift?
May 19, 2025 10:30 PM AEST| By Team Kalkine MediaHighlights,Arecor Therapeutics PLC (LSE:AREC) announced a development agreement with US-based Skye Bioscience focusing on an obesity drug formulation.,The collaboration employs Arecor’s Arestat technology to develop a higher concentration version of...
Is Creo Medical Group Set to Lead in Medical Technology Innovation in 2025?
May 19, 2025 06:30 PM AEST| By Team Kalkine MediaHighlights,Creo Medical Group has seen a strong start to 2025, with significant growth from its innovative surgical tools.,The company is expanding its product portfolio, including the launch of the Speedboat Notch and SpydrBlade Flex devices.,Strate...
What’s Fueling Hikma Pharmaceuticals in the FTSE 100 Surge?
May 19, 2025 01:38 PM AEST| By Team Kalkine MediaHighlights,Hikma Pharmaceuticals operates in the healthcare and pharmaceuticals sector, listed on the FTSE 100 index.,The share price saw a marked increase during recent trading activity, aligning with recent updates in corporate performance.,Dividen...
What’s Driving Movement in FTSE 100 Today? Worldwide Healthcare (LON:WWH) Below 50-Day Average
May 19, 2025 03:22 AM AEST| By Team Kalkine MediaHeadlines,Worldwide Healthcare Trust operates in the global healthcare sector and is listed on the London Stock Exchange,The stock recently moved below its 50-day moving average, reflecting broader performance shifts,WWH is part of FTSE indexes and o...
What Is Driving Interest in Xenon-Based MRI on the FTSE 100 Index Live?
May 16, 2025 02:31 AM AEST| By Team Kalkine MediaHighlights,Xenon MRI technology developed by Polarean Imaging (LSE: POLX) is featured in numerous clinical presentations at leading respiratory conferences.,The imaging method supports functional lung assessments in respiratory diseases including ast...
Is This FTSE Share Reshaping the Pharma Landscape with Its Latest Strategic Shift?
May 16, 2025 12:31 AM AEST| By Team Kalkine MediaHighlights,Hikma Pharmaceuticals outlined medium-term revenue growth and operational performance plans.,The firm introduced “Hikma Rx” to focus more on complex prescription drugs.,An on-site stake tour of its U.S. facility aligned with its strategy u...
What Breakthrough Is Polarean Bringing to FTSE Health-Tech via Philips Collaboration?
May 15, 2025 02:30 AM AEST| By Team Kalkine MediaHighlights,Polarean Imaging PLC (LSE: POLX) and Philips have enhanced their collaboration to expand non-invasive lung imaging in chronic disease diagnostics,Xenon MRI integration into Philips 3.0T systems aims to improve scan times and comfort for yo...
What’s Behind GSK’s Push into Liver Disease Treatments on the LSE? | Markets Today FTSE
May 14, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,GSK (LSE:GSK) has secured rights to efimosfermin, a therapy aimed at addressing steatotic liver disease,The therapy is set to enter late-stage clinical development, aligning with GSK's hepatology expansion,Steatotic liver disease affects a...
Can Genetic Testing Transform Cardiac Diagnostics on the AIM Index?
May 13, 2025 08:30 PM AEST| By Team Kalkine MediaCan Genetic Testing Transform Cardiac Diagnostics on the AIM Index?
FTSE 100 Index Surges as indexftse ukx Climbs on Trade Optimism
May 13, 2025 09:28 AM AEST| By Team Kalkine MediaHighlights,FTSE 100 marked a month-high driven by tariff agreement between the US and China,Mining and commodity firms experienced gains across the session,Pharmaceutical stocks declined amid regulatory remarks from the US administration,Mining and C...
What’s Driving the FTSE 100? Mining, Pharma, and Retail Stocks Move Markets
May 13, 2025 09:12 AM AEST| By Team Kalkine MediaHighlights,Mining stocks like Glencore and Antofagasta advanced on trade optimism,Pharmaceutical firms AstraZeneca and GSK declined amid US drug price focus,Cranswick shares dropped following supermarket supply suspensions,Mining Sector Leads Gains o...
Is Optima Health PLC Expanding its Presence in the UK Healthcare Sector?
May 13, 2025 02:30 AM AEST| By Team Kalkine MediaHighlights,Optima Health PLC continues to demonstrate resilience, showing growth despite prior challenges.,The company is diversifying into digital services and secured a major contract with the Ministry of Defence.,Strategic acquisitions, including...
Is hVIVO Leading a Clinical Revolution in the Ftse 350 Health Sector?
May 13, 2025 01:30 AM AEST| By Team Kalkine MediaHighlights,hVIVO PLC (LSE:HVO) focuses on human challenge trials, offering alternatives to traditional vaccine testing methods,The company presented advanced viral challenge models at the World Vaccine Congress, including newer strains of respiratory...
How Is a Biotech Firm on the FTSE 350 Exploring a New Path for Inflammatory Bowel Disease?
May 12, 2025 11:31 PM AEST| By Team Kalkine MediaHighlights,N4 Pharma PLC (LSE:N4P), listed on the FTSE 350, is advancing its Nuvec® delivery system for treating Inflammatory Bowel Disease (IBD).,The Nuvec® platform demonstrated reduced inflammation through oral delivery of siRNA and mRNA.,The new...
Could This Strategic Overhaul Reshape a Key Player in the FTSE AIM 100 Index?
May 12, 2025 10:31 PM AEST| By Team Kalkine MediaHighlights,Venture Life Group has divested its manufacturing operations to streamline focus on consumer healthcare brands.,The sale is structured to support debt reduction and expansion into UK, US, and EU markets.,The company has entered a decade-lo...
AI on the Rise: A Look at Top AI Companies and Their Stocks